宫颈癌药物

Cervical cancer drug

以上为机器翻译结果，快速获取精准的人工翻译结果，建议选择有道人工翻译

1
探讨ATP-肿瘤体外药敏试验（ATP-TCA）用于检测宫颈癌对化疗药物敏感性的可行性。
To explore the feasibility of the ATP-tumor chemosensitivity assay ( ATP-TCA) applied in human cervical cancer chemosensitivity testing.
2
组蛋白脱乙酰基酶抑制剂已被证实具有抗肿瘤作用，多种有关组蛋白脱乙酰基酶抑制剂的药物临床试验正在进行中，以期成为治疗宫颈癌的一个新方向。
HDI has been proved to have antitumor activities and a number of clinical trials relating to HDI are in progress. It is expected that HDI becomes a new therapy of cervical cancer.

点击反馈